joint replacement

Whether you’ve had lifelong knee issues or you’ve just started noticing discomfort when you went hiking this summer, you know just how miserable knee pain can be.

Total knee replacement is one of those surgeries that people may have delayed due to COVID, but you don’t have to live with pain any longer!

Dr. Joshua Hickman, an orthopedic surgeon at Lakeview Hospital joined us to talk about total knee replacements.

Dr. Hickman says if you’re experiencing extreme pain and limited mobility and non-surgical treatment options have not helped, it may be time to talk with your primary care physician about joint replacement surgery.

When knee pain makes it increasingly difficult to accomplish daily tasks, even normal movements like standing, bending and walking, it may be time.

Dr. Hickman says, “99% of my patients go home within 24 hours after total knee replacement surgery at Lakeview Hospital! That’s for total knee replacements and total hip replacements there. I’m happy and proud of that!

Dr. Hickman says robotic technology he uses brings the best of both worlds together – the latest advancements in medicine combined with the skills and expertise of an experienced human surgeon who’s operating that technology.

Lakeview Hospital offers a free pre-operation class to help patients make sure they’re set up for success and that no surprises come their way the day of surgery. It covers topics like preparing for surgery and the hospital, how to prevent possible complications, controlling pain, physical and occupational therapy and how to plan for the recovery at home.

In part, that class has meant more patients are walking around within only four hours after surgery. Dr. Hickman says, “We went from 90 percent of our patients doing so, to now 98 percent of patients!”

Classes are offered three times a week at Lakeview Hospital in Bountiful. A virtual class option is also available, if needed.

Once surgery is over, Dr. Hickman says he always visits with patients and their loved ones to ensure they’re getting the proper education and instructions for the best recovery possible.

If you’d like more information head to LakeviewHospital.com or MountainStar.com.

The future is now at Elmhurst Hospital Center. NYC Health + Hospitals announced that it has acquired the Stryker Mako SmartRobotics system to perform robotic-assisted hip and knee replacement procedures. This new surgical option at Elmhurst Hospital offers patients a minimally invasive alternative for total hip, total knee and partial knee replacements.

The highly advanced technology used in robotic surgery for joint replacement enables patients to recover faster and more effectively. Elmhurst Hospital is the first within the city’s public hospital system to introduce the Mako robotic surgical procedure.

“NYC Health + Hospitals/Elmhurst is happy to be able to offer the Stryker Mako SmartRobotics system as an option for our patients,” said NYC Health + Hospitals/Elmhurst CEO Helen Arteaga Landaverde. “This demonstrates our commitment to providing the highest quality health care to our orthopedic patients as well as our continuing efforts to embrace advanced technology so that our community has the care it needs and deserves.”

Mako SmartRobotics is a treatment option designed to relieve the pain caused by joint degeneration due to osteoarthritis. During surgery, the surgeon guides the robotic arm during bone preparation to execute the predetermined surgical plan and position the implant. Studies have shown that robotic-arm assisted joint replacement surgery leads to greater accuracy of implant position compared to manual partial joint replacement procedures. Other benefits for patients include less pain, less need for opiate analgesics, less need for inpatient physical therapy, and a reduction in length of hospital stay.

“The Mako robotic system, which combines 3D CT-based planning with data analytics, allows us to create a more personalized plan for each patient based on their unique anatomy before surgery,” said Dr. Rohit Hasija, Elmhurst’s Hip and Knee Program director. “During surgery, we can then confirm that plan and adjust if needed, all the while guiding a surgical robotic arm to perform that plan. We are thrilled to be able to offer these advanced techniques as part f the care we provide as we believe them to lead to better outcomes for total knee, total hip, and partial knee patients.”

NYC Health + Hospitals also announced the reopening of the Neponsit Adult Day Health Center in Rockaway Park, which closed in March 2020 at the start of the COVID-19 pandemic. The center, located at 230 Beach 102nd St., provides on-site services for approximately 50 patients daily.

“We are excited to welcome our registrants back,” said Khoi Luong, DO, Senior Vice President for Post-Acute Care. “The center plays a vital role in the lives of our registrants, and we know that the pandemic has been a huge disruption in their lives. While the center was closed, our social workers stayed in touch with every registrant to ensure that their care needs were being met. Today is like a homecoming.”

Originally opened in 1988, the center has provided services including nursing, physical therapy, nutrition assessment, occupational therapy, medical social services, psychosocial assessment, rehabilitation and socialization, and coordination of referrals for outpatient health. Those interested in learning more about the center and its services can call 718-634-1400. The center accepts Medicaid, private payment, and some health insurers.

For many years, there has been a gender discrepancy in orthopedic surgery. Because research has an impact on promotions, researchers for a study sought to determine the patterns in female authorship in three journals over the last 25 years for both first and senior authors. From 1995 through 2020, all publications from the Journal of Bone and Joint Surgery, Journal of the American Academy of Orthopaedic Surgeons, and Clinical Orthopaedics and Related Research were downloaded in 5-year intervals, and data for first and senior authors were retrieved. The first and senior writers’ genders were identified using the proven Genderize method. Chi-square tests were used to examine the demographics of the first and senior author cohorts. Logistic regression models were used to examine trends in female authorship while adjusting for year and journal. 

In the journals examined, 5,636 people were recognized as first authors and 4,572 as senior authors. For 82.59% of the writers, the gender was determined. From 1995 to 2020, female first authorship grew considerably (6.70% to 15.37%, P<0.001). Similarly, female senior authorship grew considerably between 1995 and 2020 (8.22% to 13.65%, P<0.001). Overall, there was no statistically significant variation in the gender mix of authors among journals (P=0.700 first author and P=0.098 senior author). However, women were much more likely to publish as first or senior authors in subsequent years, regardless of the journal (P<0.001 for the first author and P<0.001 for senior authors).

Female authorship in prestigious orthopedic journals rose significantly between 1995 and 2020, with inter-journal disparities in senior author gender discrepancy. Despite the fact that female orthopedic surgeons publish at rates comparable to or greater than their participation in the field, more study into the continuation of gender discrepancies in orthopedics is required.

Reference:journals.lww.com/jaaos/Abstract/2022/06150/Evolution_and_Trends_in_Male_Versus_Female.10.aspx

FOSTER CITY, Calif., April 8, 2022 /PRNewswire/ — OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company and its collaborators present clinical data strongly supporting joint bone shape change as part of a surrogate marker predictive of joint replacement in knee osteoarthritis (OA) patients.

An abstract entitled, “Improved WOMAC Physical Function is Associated with Slowed Pathological Bone Shape Change after TPX-100: Towards a Surrogate Marker for Virtual Knee Replacement?” was presented today in a Plenary Session of 2022 OARSI World Congress on Osteoarthritis in Berlin, Germany (Abstract 26 in Osteoarthritis and Cartilage Vol. 30 Suppl. S28–S29).

Functional impairment is a key risk factor for knee replacement even after adjusting for knee pain severity, based on the large NIH-sponsored Multicenter Osteoarthritis Study (the “MOST” study) involving over 5,500 knees. In the TPX-100-5, a Phase 2 study, placebo-treated knees with more advanced pathological joint bone shape change at baseline showed much faster progression of pathological bone shape change and poorer knee function at the end of the 12-month study period. In marked contrast, TPX-100-treated knees demonstrated reduction in pathological bone shape change and robust improvement of knee function through 12 months, regardless of severity at baseline. Consequently, both clinical (knee function) and structural (bone shape) efficacies of TPX-100 as compared to placebo were confirmed including in subjects with moderate to severe knee OA.

“The current FDA draft guidance indicates that a positive effect on an imaging marker of OA must be associated with avoidance or delay of the need for joint replacement, or must persuasively reduce deterioration of function and worsening of pain. This is a high bar,” commented Dr. Dawn McGuire, OrthoTrophix’ Chief Medical Officer. “However, the Multicenter Osteoarthritis Study findings and our clinical data collectively suggest that concordant improvements of bone shape change and clinical function could lead to a delay or elimination of the need for joint replacement surgery. These combined outcomes in structure and function could provide a ‘virtual joint replacement’ measure for the study of disease-modifying agents in individuals afflicted with knee OA.”

The Company also will present an abstract entitled, “Intra Articular TPX-100 Significantly Improves Pain Measures and Slows Pathological Bone Shape Chage in Knee OA”. This presentation demonstrates clinically meaningful improvements in overall knee pain and in specific key pain parameters in moderate to severe knee OA, linked to significant reductions in pathological bone shape change (Abstract 254 in Osteoarthritis and Cartilage Vol. 30 S193).

About OrthoTrophix, Inc.
OrthoTrophix, Inc., based in the San Francisco Bay Area, California, is a privately held biopharmaceutical company focused on development and commercialization of a first-in-class Disease Modifying Osteoarthritis Drug (DMOAD). Founded by three co-founders in 2011, the primary focus of OrthoTrophix has been regeneration and repair of cartilage and underlying bones in the knee and other joints with its novel proprietary compounds.

This press release contains “forward-looking” statements. These statements involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements include statements regarding product development and cannot be guaranteed. OrthoTrophix undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect OrthoTrophix’ business.

Company Contact
Yoshi Kumagai
President and CEO
Tel: (510) 488-3824

SOURCE OrthoTrophix, Inc.

Skip to content

Depending on what you do for a living, it’s very likely that your job is highly stressful. Your entire day could be spent performing repetitive motions such as lifting heavy objects or moving around. It’s essential to take care of your body’s muscles, joints, and nerves before things get worse.

An orthopedic surgeon specializes in the health of the musculoskeletal system and can help you figure out what’s wrong and how to fix it. For those who aren’t familiar with orthopedists, here are a few things to keep in mind when deciding whether or not to see one:

Having Difficulty Climbing the Stairs 

Joints in the knees and hips naturally begin to deteriorate with age, which typically makes it too uncomfortable for the affected body parts to continue functioning normally. If you have trouble walking, climbing stairs, or getting out of chairs, it may be time for your doctor to propose that you have joint surgery. 

Joint injury can manifest itself in various ways, one of which is chronic pain that lasts for more than six months and disrupts daily life. A joint replacement may be necessary for a variety of reasons, including accidents that may have occurred in the past and years of heavy use. 

Instability Of Joints. 

Destabilization is merely one more compelling argument in favor of seeking the counsel and expertise of an orthopedic physician. Should people who have trouble standing, walking, or moving easily investigate the possibility that they have orthopedic problems? Many of them do. The easiest method to go about doing this is to seek the advice of a specialist who is already working in the sector. 

Having a Hard Time with Chores. 

The capacity to carry out daily activities without the assistance of another person is referred to as self-sufficiency. To accomplish this, you must be able to get out of bed with only minimal assistance, dress, bend over to tie your shoes, prepare your meals, and so on. 

Consult AOA Orthopedic Specialists if you are unable to execute the tasks at hand without experiencing significant discomfort or if the manner in which you are expected to carry them out is undergoing significant change. 

Disturbances in Bowel Movement and Bladder Function 

If you find yourself rushing to the bathroom or sitting on the toilet for hours at a time, which is neither pleasant nor normal, it may be time to consult a doctor. Both irritable bowel syndrome (also known as IBS) and nerve injury can have adverse effects on the intestines, the bladder, and the back. 

Irritable bowel syndrome (IBS) can cause abdominal cramping and extreme stool, both of which are indicators that your bowel system isn’t functioning correctly. This can lead to problems in the lower back. On the other hand, injury to the nerves in the back can lead to discomfort in the abdomen and make digestion difficult. 

Bottom Line

You put yourself in jeopardy of long-term damage and impairment if you ignore what your body is trying to tell you. There are several warning signs that should prompt a person to seek medical attention, particularly from an orthopedic specialist. These warning signs include problems with the joints and bones.

Safiri, S. et al. Global, regional and national burden of osteoarthritis 1990–2017: A systematic analysis of the Global Burden of Disease Study 2017. Ann. Rheum. Dis. 79, 819–828 (2020).

PubMed 
Article 

Google Scholar 

Ackerman, I. N. et al. The substantial personal burden experienced by younger people with hip or knee osteoarthritis. Osteoarthr. Cartil. 23, 1276–1284 (2015).

CAS 
Article 

Google Scholar 

Zambon, S. et al. Role of osteoarthritis, comorbidity, and pain in determining functional limitations in older populations: European project on osteoarthritis. Arthritis Care Res. 68, 801–810 (2016).

Article 

Google Scholar 

Carr, A. J. et al. Knee replacement. Lancet (Lond., Engl.) 379, 1331–1340 (2012).

Article 

Google Scholar 

Ferket, B. S. et al. Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative. BMJ 356, 1131 (2017).

Article 

Google Scholar 

Food, U. & Administration, D. Osteoarthritis: structural endpoints for the development of drugs, devices, and biological products for treatment guidance for industry. FDA. gov http://www.fda.gov/downloads/Drugs/GuidanceCmplianceRegulatoryInformation/Guidances/ucm071577.pdf (2018).

Saisho, Y. Metformin and inflammation: Its potential beyond glucose-lowering effect. Endocr. Metab. Immune Disord.s-Drug Targets 15, 196–205 (2015).

CAS 
Article 

Google Scholar 

Golay, A. Metformin and body weight. Int. J. Obes. 32, 61–72 (2008).

CAS 
Article 

Google Scholar 

Seifarth, C., Schehler, B. & Schneider, H. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Exp. Clin. Endocrinol. Diabetes 121, 27–31 (2013).

CAS 
PubMed 

Google Scholar 

Björkhem-Bergman, L., Asplund, A. B. & Lindh, J. D. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: A systematic review and meta-analysis. J. Psychopharmacol. 25, 299–305 (2011).

PubMed 
Article 

Google Scholar 

Harborne, L. R., Sattar, N., Norman, J. E. & Fleming, R. Metformin and weight loss in obese women with polycystic ovary syndrome: Comparison of doses. J. Clin. Endocrinol. Metab. 90, 4593–4598 (2005).

CAS 
PubMed 
Article 

Google Scholar 

Kim, S. A. & Choi, H. C. Metformin inhibits inflammatory response via AMPK–PTEN pathway in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 425, 866–872 (2012).

CAS 
PubMed 
Article 

Google Scholar 

Łabuzek, K., Liber, S., Suchy, D. & Okopień, B. A successful case of pain management using metformin in a patient with adiposis dolorosa. Int. J. Clin. Pharmacol. Ther. 51, 517–524 (2013).

PubMed 

Google Scholar 

Kalariya, N. M., Shoeb, M., Ansari, N. H., Srivastava, S. K. & Ramana, K. V. Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 53, 3431–3440 (2012).

CAS 
PubMed 
PubMed Central 
Article 

Google Scholar 

Berenbaum, F., Griffin, T. M. & Liu-Bryan, R. Review: Metabolic regulation of inflammation in osteoarthritis. Arthritis Rheumatol. 69, 9–21 (2017).

PubMed 
PubMed Central 
Article 

Google Scholar 

Song, P. et al. Therapeutic applications of type 2 diabetes mellitus drug metformin in patients with osteoarthritis. Pharmaceuticals 14, 152 (2021).

CAS 
PubMed 
PubMed Central 
Article 

Google Scholar 

Lu, C.-H. et al. Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan. PLoS ONE 13, e0191242 (2018).

PubMed 
PubMed Central 
Article 

Google Scholar 

Wang, Y. et al. Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative—a prospective cohort study. Arthritis Res. Ther. 21, 127 (2019).

PubMed 
PubMed Central 
Article 

Google Scholar 

Mohammed, M. M., Al-Shamma, K. J. & Jassim, N. A. Evaluation of the clinical use of metformin or pioglitazone in combination with meloxicam in patients with knee osteoarthritis; using knee injury and osteoarthritis outcome score. Iraq. J. Pharmac. Sci. 23, 13–23 (2014).

Google Scholar 

Chowdhury, T. T. et al. Dynamic compression counteracts IL-1β induced inducible nitric oxide synthase and cyclo-oxygenase-2 expression in chondrocyte/agarose constructs. Arthritis Res. Ther. 10, R35 (2008).

CAS 
PubMed 
PubMed Central 
Article 

Google Scholar 

Gosset, M. et al. Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene. Arthritis Res. Ther. 8, R135 (2006).

PubMed 
PubMed Central 
Article 

Google Scholar 

Gabay, O. et al. Stress-induced signaling pathways in hyalin chondrocytes: Inhibition by Avocado-Soybean Unsaponifiables (ASU). Osteoarthr. Cartil. 16, 373–384 (2008).

CAS 
Article 

Google Scholar 

Fitzgerald, J. B. et al. Shear-and compression-induced chondrocyte transcription requires MAPK activation in cartilage explants. J. Biol. Chem. 283, 6735–6743 (2008).

CAS 
PubMed 
Article 

Google Scholar 

Wang, X.-Q. et al. A meta-analysis of core stability exercise versus general exercise for chronic low back pain. PLoS ONE 7, e52082 (2012).

ADS 
CAS 
PubMed 
PubMed Central 
Article 

Google Scholar 

Gomez, R., Lago, F., Gomez-Reino, J., Dieguez, C. & Gualillo, O. Adipokines in the skeleton: Influence on cartilage function and joint degenerative diseases. J. Mol. Endocrinol. 43, 11–18 (2009).

CAS 
PubMed 
Article 

Google Scholar 

King, L. K., March, L. & Anandacoomarasamy, A. Obesity & osteoarthritis. Indian J. Med. Res. 138, 185–193 (2013).

PubMed 
PubMed Central 

Google Scholar 

Arslan, I. et al. Underrecoding of knee osteoarthritis: A population-based study with electronic health records in Dutch general practice. Osteoarthr. Cartil. 29, S70–S71 (2021).

Article 

Google Scholar 

Wong, L., et al. Accuracy and completeness of ICPC coding for chronic disease in general outpatient clinics. Hong Kong Practitioner (2010).

Yung, C.S.-Y. et al. Unicompartmental knee arthroplasties in Hong Kong: 15 years of experience in a teaching hospital. J. Orthop. Surg. 27, 2309499019850364 (2019).

Google Scholar 

Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393–403 (2002).

CAS 
PubMed 
Article 

Google Scholar 

Li, Y., Liu, L., Wang, B., Wang, J. & Chen, D. Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomed. Rep. 1, 57–64 (2013).

CAS 
PubMed 
Article 

Google Scholar 

Quinn, B. J., Kitagawa, H., Memmott, R. M., Gills, J. J. & Dennis, P. A. Repositioning metformin for cancer prevention and treatment. Trends Endocrinol. Metab. 24, 469–480 (2013).

CAS 
PubMed 
Article 

Google Scholar 

Kasznicki, J., Sliwinska, A. & Drzewoski, J. Metformin in cancer prevention and therapy. Ann. Transl. Med. 2, 2 (2014).

Google Scholar 

Corte, C. M. D. et al. Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells. Oncotarget 7, 22 (2015).

Google Scholar 

Morgillo, F. et al. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer. ESMO Open 2, 31 (2017).

Article 

Google Scholar 

Salvatore, T. et al. Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects?. Biomedicines 9, 25 (2021).

Article 

Google Scholar 

Salvatore, T. et al. Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence. Biomolecules 11, 32 (2021).

Article 

Google Scholar 

Salvatore, T. et al. Metformin: A potential therapeutic tool for rheumatologists. Pharmaceuticals 13, 63 (2020).

MathSciNet 
Article 

Google Scholar 

Salvatore, T. et al. Metformin: An old drug against old age and associated morbidities. Diabetes Res. Clin. Pract. 160, 108025 (2020).

CAS 
PubMed 
Article 

Google Scholar 

Newman, S., Steed, L. & Mulligan, K. Self-management interventions for chronic illness. Lancet 364, 1523–1537 (2004).

PubMed 
Article 

Google Scholar 

Zhang, Z., Kim, H. J., Lonjon, G. & Zhu, Y. Balance diagnostics after propensity score matching. Ann. Transl. Med. 7, 16–16 (2019).

CAS 
PubMed 
PubMed Central 
Article 

Google Scholar 

Ho, D., Imai, K., King, G. & Stuart, E. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit. Anal. 15, 199–236 (2007).

Article 

Google Scholar 

Therneau, T.M. Mixed Effects Cox Models [R package coxme version 2.2–16]. (2018).

Irvine, Calif.-based Hoag Orthopedic Institute added a second robot to its technology lineup.

Hoag began using the Velys robot from Johnson & Johnson, according to a May 18 news release. So far more than 25 cases have been completed with it. Nader Nassif, MD, chief of joint replacement, was one of the first surgeons to use the robot.

“We realize through many studies that a percentage of knee replacement patients still have some pain, stiffness or are just not satisfied with their new knee, even though they would agree that they would have still undergone the procedure,” Dr. Nassif said in the release. “If the robot can help reduce that small percentage of unsatisfied patients even more, we have made progress.”

 

Irvine, Calif.-based Hoag Orthopedic Institute has added two total joint replacement robots at its ASCs, the hospital said Aug. 15.

Hoag Orthopedic’s surgery center in Mission Viejo, Calif., added the Rosa knee robot, and its ASC in Orange, Calif., added a Corin OMNIBiotics system, Hoag stated in a news release. The new additions bring Hoag’s total to four knee replacement robots at its facilities.

“Robots in general don’t make a surgeon better, but the next-generation robotic devices have the potential to augment a good surgeon’s skill,” Nader Nassif, MD, Hoag Orthopedic Institute’s division chief of joint replacement, said in the news release.

Another robot is slated to be included later this year at Hoag’s upcoming surgery center in Aliso Viejo, Calif.